about
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotesSpermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseasesExperimental methods to preserve male fertility and treat male factor infertilityOrigins of Programmable Nucleases for Genome EngineeringThe complexity of epigenetic diseasesEngineering large animal models of human diseaseSynthetic biology and occupational riskCRISPR/Cas9 and mitochondrial gene replacement therapy: promising techniques and ethical considerationsGenetic Moderation of Stress Effects on Corticolimbic CircuitryA CRISPR New World: Attitudes in the Public toward Innovations in Human Genetic Modification.CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.The moral imperative to continue gene editing research on human embryos.Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework.What is CRISPR/Cas9?Core Concept: CRISPR gene editing.A double-edged sword: CRISPR-Cas9 is emerging as a revolutionary technique for genome editingThe societal opportunities and challenges of genome editing.No time to waste--the ethical challenges created by CRISPR: CRISPR/Cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cellsHuman germ line editing-roles and responsibilitiesA mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9Stepping Into and Out of the Void: Funding Dynamics of Human Embryonic Stem Cell Research in California, Sweden, and South KoreaGene Editing and Germ-line Intervention: The Need for Novel Responses to Novel TechnologiesA CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular ResearchApplication of the genome editing tool CRISPR/Cas9 in non-human primates.CRISPR, a Crossroads in Genetic Intervention: Pitting the Right to Health against the Right to Disability.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Germ line genome editing in clinics: the approaches, objectives and global society.Mitochondrial Modification Techniques and Ethical Issues.A Reminiscence about Early Times of Vitreous Water in Electron CryomicroscopyCRISPR-Cas: From the Bacterial Adaptive Immune System to a Versatile Tool for Genome Engineering.Modeling Disease In Vivo With CRISPR/Cas9.Human Germline Genome Editing."I bet you won't": The science-society wager on gene editing techniques.Genetically engineering milk.CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials.Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.CRISPR: taking the shortcut to a healthy genome editing enterprise.Beyond The Anticipatory Corpse-Future Perspectives for Bioethics.CRISPR as a driving force: the Model T of biotechnology.The Future of Cardiovascular Regenerative Medicine.
P2860
Q22337358-B09A3DE0-7EB4-4945-9536-1F73FAFA1A2BQ26744780-30BE7DE8-1197-4516-B964-F2365F120734Q26770116-ACFCF737-3A56-4344-9B49-8F7D4B14493EQ26778501-C67728E7-31D8-4064-B7CB-7D705C6FC58BQ26784416-58C4C919-91F5-4574-83BF-6B39F68117D8Q26785547-30BBAF1F-F2CE-45F2-94F3-F674B8BE3CCDQ27968974-0154B45D-36DC-46DD-BC0F-48FB37C29234Q28073860-E7A6658F-898F-4A24-8D46-301B1DF5218AQ28606435-984ADAAC-DF8D-474E-9649-77240D54733AQ33711428-E55EC4A8-1A5D-43D0-9649-55E3AD468C24Q33830117-FD3E4759-D58D-465E-A256-16E9C0555FDAQ34482434-93468FE9-22B9-4A0D-AFF8-9F765E793E5DQ34503980-9DC854D8-336B-457D-9592-6DDA093781D9Q34521342-0FC74AAC-4BED-444F-B9EB-4E20A4964CE2Q35644973-F5DD496A-8D62-451C-BA3C-DD390B5B3D5FQ36165753-945C431B-FD98-4854-9502-78C980047525Q36253010-A9A42E14-5078-4789-A98F-EFD00385580FQ36270836-29DB571E-F43E-4388-A8E1-ADB3D92BE535Q36447877-0D432A7C-A7C5-4699-ACCA-4161EF6A4C7EQ36483327-CFDC75A8-4595-4457-8F2F-97293E181390Q36484522-0F53694F-5C3D-4EED-B117-33A14704103CQ36757166-D039D085-1987-4C61-AC41-57B8A88B8F89Q36940626-FA909060-5E6F-467A-A3C1-31FF28B1B80FQ37165527-D0FA0F83-4F06-4E73-B4E9-BBAE12FF52B5Q37287970-4401FFEE-D7BA-4083-AB11-C4D7D6D1F0B9Q37573646-06178FEF-62D2-42EA-B026-0C12741BC5D6Q37623660-E712377D-9EB7-45B7-891A-D977402A87DDQ37729935-498A3A4E-708A-4B54-82DD-5B5CE16BF9C7Q38585291-D41B5733-B444-4A92-8D79-8B99242EDE68Q38588821-E057F40A-B175-4FA6-8E85-DA0D933AA232Q38598073-5A5BC063-F374-4497-A3C0-C2F85054D997Q38646763-512D54E8-679E-4291-916F-E4E3404D4398Q38699859-08121304-BE89-4620-82F8-A0395DEDD9C4Q38730453-9439809C-8C39-496A-8EEC-08C67082FD86Q38746615-94C13FFF-F022-4976-88CD-EBE5C65661CEQ38757108-E8CF6314-86EB-4BE5-AE50-DE7AA3F97B56Q38769450-DD7D37DE-EF9E-40E8-B296-96DADBEA7AF3Q38809089-22ADDBE7-7922-4EA0-9090-89F996F6657EQ38822064-90D8FE12-E0D4-4C94-AC96-566AF00D0D78Q38850633-464545E1-A04D-4C28-B547-F68EFD9B33B4
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Don’t edit the human germ line
@ast
Don’t edit the human germ line
@en
Don’t edit the human germ line
@en-gb
Don’t edit the human germ line
@nl
type
label
Don’t edit the human germ line
@ast
Don’t edit the human germ line
@en
Don’t edit the human germ line
@en-gb
Don’t edit the human germ line
@nl
altLabel
Don't edit the human germ line
@en
prefLabel
Don’t edit the human germ line
@ast
Don’t edit the human germ line
@en
Don’t edit the human germ line
@en-gb
Don’t edit the human germ line
@nl
P2093
P3181
P356
P1433
P1476
Don’t edit the human germ line
@en
P2093
Edward Lanphier
Fyodor Urnov
Joanna Smolenski
Michael Werner
Sarah Ehlen Haecker
P2888
P304
P3181
P356
10.1038/519410A
P407
P577
2015-03-12T00:00:00Z
P5875
P6179
1033238382